Altre lingue Sumitomo Pharma Co., Ltd.

Azioni

4506

JP3495000006

Mercato chiuso - Japan Exchange Altri mercati azionari 08:00:00 21/05/2024			Variaz. 5gg	Var. 1 gen.
309 ^JPY	-8,85%		-25,72%	-33,69%

07/05	Presa di profitto, prospettive della Cina agitano i mercati azionari asiatici	MT
02/05	Le prospettive della Fed, la stagione degli utili fanno tremare i mercati azionari asiatici	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Sumitomo Pharma : Posted Conference on FY2023 Financial Results	20/05
Poxel : un chiffre d'affaires trimestriel de 449000 euros	17/05
Sumitomo Chemical Co., Ltd. - Announcement of Finance Income, Restructuring Costs, and Extraordinary Loss in Non-consolidated Financial Statements	16/05
Sumitomo Pharma : May 14, 2024 Conference on FY2023 (April 1, 2023 to March 31, 2024) Financial Results	14/05
Sumitomo Pharma : Appoints Toru Kimura as President and CEO and Changes in Board of Directors Including Representative Directors, Executive Officer, and the Positions Assumed by Executive Officers	14/05
Sumitomo Pharma : Presentation Material (Conference on FY2023 Financial Results)	14/05
Sumitomo Pharma : Start of Phase 1 Clinical Study on Novel Universal Influenza Vaccine Candidate	14/05
Sumitomo Pharma : Notice of Company Split (Simplified Absorption-type Company Split) of the Frontier Business and Notice of Business Acquisition by a Wholly-Owned Subsidiary of the Company	09/05
Sumitomo Pharma Co., Ltd. agreed to acquire MELTz Business of MELTIN MMI Co., Ltd.	09/05
Profit-Taking, China Outlooks Churn Asian Stock Markets	07/05
Sumitomo Pharma : Posted Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024	07/05
Sumitomo Pharma : May 01, 2024 Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024 transcript	07/05
Fed Outlook, Earnings Season Roil Asian Stock Markets	02/05
Sumitomo Pharma Sees Impairment Losses and Restructuring Expenses in Fiscal 2024	02/05
Sumitomo Pharma Expects Substantial Valuation Loss on Subsidiary Shares; Assures No Impact on Consolidated Profit	02/05
Sumitomo Pharma : May 01, 2024 Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024	02/05
Sumitomo Pharma : Presentation Material (Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024)	30/04
Poxel : reporte la publication de ses résultats annuels 2023	29/04
Lull in Geopolitical Tensions Lifts Asian Stock Markets	22/04
Roivant Sciences Says Study of Potential Uveitis Treatment Meets Endpoints; Launches Stock Repurchase; Shares Rise	02/04

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Sumitomo Pharma Co., Ltd.

Azioni

4506

JP3495000006

Altre lingue

Filtri